跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,600 条关于
“AMI Organics”
全部
8,600
临床试验
5,091
药物
538
机构
78
资讯
2,893
去年
Anlon Healthcare Sets IPO Price Band at ₹86-91 Per Share for ₹121 Crore Public Offering
去年
AMI Pharm's AYP-101 Enters Phase 3 Trial for Non-Inflammatory Fat Reduction
3个月前
FDA Investigates Second Infant Botulism Outbreak Linked to Organic Powdered Formula in Seven Months
去年
REDUCE-AMI Trial Re-evaluates Beta-Blocker Use Post-Myocardial Infarction
6个月前
DOBERMANN Trials Test Early Interventions to Prevent Cardiogenic Shock in High-Risk AMI Patients
去年
Progranulin Levels Surge Post-Myocardial Infarction, Correlating with Improved Cardiac Function
去年
Patient Health Engagement Model Enhances Cardiac Rehabilitation Participation After AMI
去年
Tocilizumab Investigated for Acute Myocardial Infarction with Cardiogenic Shock
2年前
CellProthera Advances ProtheraCytes Cell Therapy Program for Myocardial Infarction with FDA Alignment on Phase III Trial Design
去年
FDA Grants Fast Track Designation to Sungen Biomedical's Novel Antibody for Acute Myocardial Infarction
第 1 页,共 290 页
上一页
下一页